Press release
Ischemic Stroke Pipeline Analysis Demonstrates Novel 50+ Therapies at the Horizon Expected to Transform the Treatment Paradigm | DelveInsight
In the Ischemic Stroke pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, Ischemic Stroke clinical trials studies, Ischemic Stroke NDA approvals (if any), and product development activities comprising the technology, Ischemic Stroke collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Key takeaways from the Ischemic Stroke Pipeline Report
• DelveInsight's Ischemic Stroke pipeline report depicts a robust space with 50+ active players working to develop 50+ pipeline therapies for Ischemic Stroke treatment.
• The leading Ischemic Stroke Companies includes Athersys Inc., Tarveda Therapeutics, Lumosa Therapeutics, Teijin Pharma Limited, NC Medial Research Inc, Acticor Biotech, Meridigen Biotech Co., Ltd., GrandPharma (China) Co., Ltd., Suzhou Yabao Pharmaceutical R&D Co., Ltd., Prolong Pharmaceuticals, Nanjing Yoko Biomedical Co., Ltd., TrueBinding, Inc., GNT Pharma, Roche, DiaMedica Therapeutics Inc, aptaTargets, and others.
• Promising Ischemic Stroke Pipeline Therapies includes MultiStem, SB623 Implant (2.5M), Sham surgery, Stent retriever (TonbridgeMT), Solitaire™, Cerebrolysin, YM872 (zonampanel), t-PA (alteplase), JTR-161, Ginkgolides Meglumine Injection, SP-8203, and others.
• The Ischemic Stroke companies and academics that are working to assess challenges and seek opportunities that could influence Ischemic Stroke R&D. The Ischemic Stroke pipeline therapies under development are focused on novel approaches to treat/improve the disease condition.
To explore more information on the latest breakthroughs in the Ischemic Stroke Pipeline treatment landscape of the report, click here Ischemic Stroke Pipeline Outlook @ https://www.delveinsight.com/sample-request/ischemic-stroke-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Ischemic Stroke Overview
Ischemic strokes occur when blood supply is cut off to part of the brain. This type of stroke accounts for the majority of all strokes. The blocked blood flow in an ischemic stroke may be caused by a blood clot or by atherosclerosis, a disease which causes narrowing of the arteries over time. Ischemic strokes can be caused by a blockage anywhere along the arteries feeding the brain. Immediate emergency treatment is critical to surviving a stroke with the least amount of damage to the brain and ability to function. Ischemic strokes occur when blood supply is cut off to part of the brain by a blood clot or narrowing of the arteries.
Latest Developmental Activities or News of the Ischemic Stroke Treatment Landscape
• In July 2022, ACTICOR BIOTECH announced that it had received "PRIority Medicines" status from the European Medicines Agency (EMA) for its drug candidate, glenzocimab, for the treatment of patients with stroke.This status allowed Acticor Biotech to strengthen interactions and obtain early dialogues with regulatory authorities in order to confirm the clinical development plan for glenzocimab in the treatment of stroke.
• In July 2022, NervGen Pharma announced the University of Cincinnati and Case Western Reserve University (CWRU) had published a pioneering preclinical study in the peer-reviewed scientific journal Cell Reports demonstrating that NervGen's proprietary drug, NVG-291-R, promotes nervous system repair and significant functional recovery in a mouse model of severe ischemic stroke, even when treatment was initiated up to 7 days after onset.
• In June 2022, Pharmazz Inc released positive topline results for its Phase III clinical trial that evaluated sovateltide as a treatment for acute ischemic stroke.The findings showed that, at 90 days, the modified Rankin Score (mRS) had a significantly greater number of individuals with an improvement of 2 points or greater on mRS, mRS with a significant median score reduction, and a significantly greater reduction of individuals with an improvement of 6 or more points on the NIHSS Level of Consciousness (1A)
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Contact Us
Yash Bhardwaj
info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ischemic Stroke Pipeline Analysis Demonstrates Novel 50+ Therapies at the Horizon Expected to Transform the Treatment Paradigm | DelveInsight here
News-ID: 2924503 • Views: …
More Releases from DelveInsight Business Research
Panic Disorder Market Forecast 2032: Rising Global Prevalence and Emerging Thera …
DelveInsight's "Panic Disorder Market Insights, Epidemiology, and Market Forecast-2032" report delivers a comprehensive evaluation of Panic Disorder, covering historical data, current trends, and future projections across major global markets, including the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
This latest healthcare market forecast offers an extensive assessment of the Panic Disorder landscape, providing detailed insights into revenue patterns, disease prevalence, and evolving treatment approaches. The…
Catheter-related Bloodstream Infection (CRBSI) Pipeline Therapies Analysis 2025: …
DelveInsight's analysis highlights that the Catheter-related Bloodstream Infection (CRBSI) pipeline features over five leading companies actively advancing more than five therapeutic candidates aimed at improving CRBSI management.
DelveInsight's "CRBSI Pipeline Insight 2025" report delivers an in-depth evaluation of ongoing clinical research activities and future growth opportunities within the CRBSI therapeutics landscape.
The Surgical Site Infections Pipeline report offers comprehensive clinical and commercial insights into pipeline candidates ranging from preclinical and discovery stages…
Hepatitis C Virus (HCV) Infection Pipeline Therapies 2025: Over 20 Companies Dri …
According to DelveInsight's evaluation, the global Hepatitis C Virus (HCV) Infection pipeline features more than 20 prominent pharmaceutical and biotechnology companies actively engaged in the development of over 20+ therapeutic candidates. The analysis spans clinical trial activity, therapeutic approaches, mechanisms of action, routes of administration, and recent developments shaping the Hepatitis C Virus Infection treatment landscape.
The "Hepatitis C Virus Infection Pipeline Insight, 2025" report published by DelveInsight delivers an in-depth…
Surgical Site Infections Pipeline Therapies Analysis 2025: Over 5 Companies Driv …
Surgical Site Infections Pipeline Insight 2025: Over 5 Companies Driving Innovation Across 5+ Therapies | DelveInsight
(Albany, United States) According to DelveInsight's analysis, the global Surgical Site Infections pipeline includes more than 5 leading companies actively engaged in the development of over 5 potential SSI therapies. The report provides detailed analysis across clinical trials, therapeutic approaches, mechanisms of action, routes of administration, and recent developmental activities.
DelveInsight's "Surgical Site Infections Pipeline Insight,…
More Releases for Ischemic
Acute Ischemic Stroke (AIS) Market Demand 2034
Market Overview
The Acute Ischemic Stroke (AIS) Market continues to expand due to rising global incidence of stroke, increasing aging populations, and rapid adoption of advanced diagnostic and therapeutic technologies. AIS occurs when a blood clot obstructs an artery supplying the brain, leading to reduced blood flow and neuronal damage. The disease represents the majority of all stroke cases worldwide, and healthcare systems are increasingly prioritizing early diagnosis and treatment to…
Rising Hypertension Fuels Growth In Acute Ischemic Stroke Therapeutics Market: K …
The Acute Ischemic Stroke Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Acute Ischemic Stroke Therapeutics Market Size During the Forecast Period?
The acute ischemic stroke therapeutics market has experienced significant growth in recent years. It is projected to rise from…
Ischemic Stroke Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Ischemic Stroke Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Ischemic Stroke pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Ischemic Stroke Pipeline Report
• Over 50+ Ischemic Stroke…
Ischemic Cardiomyopathy Treatment Market Growth, Challenges, Opportunities and E …
"The new report has been added by qyresearch.com to provide detailed insight into the global Ischemic Cardiomyopathy Treatment market. The study will help to get a better understanding about the Ischemic Cardiomyopathy Treatment industry competitors, a channel for the distribution, Ischemic Cardiomyopathy Treatment growth potential, potentially disruptive trends, Ischemic Cardiomyopathy Treatment industry product innovations, market size value/volume (regional/country level, Ischemic Cardiomyopathy Treatment industry segments), market share of top players/products.
Due to…
Transient Ischemic Attack Market Forecast by 2025
Recent Transient Ischemic Attack market research and the current scenario as well as future market potential of "Global Transient Ischemic Attack Market Professional Survey Report 2020". The Transient Ischemic Attack Market comprehensively describes the market and prognosticates it to describe a highly illustrious growth during the anticipated years. The report offers an in-depth analysis of current and future Transient Ischemic Attack Market outlook across the globe. The report is projected…
Acute Ischemic Stroke Diagnosis And Treatment Market : Increased Usage of Advanc …
A recent report on global acute ischemic stroke diagnosis and treatment market has been analyzed by Transparency Market Research (TMR). The market for acute ischemic stroke diagnosis and treatment is expected to increase during the forecast period with the increasing incidence of strokes, technically advanced techniques, and successful results through treatment surgeries. Technological advancement and constant efforts made by leading companies are providing improved treatments for people suffering from ischemic…
